1.15Open1.15Pre Close0 Volume2 Open Interest70.00Strike Price0.00Turnover287.77%IV101.67%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier12DDays to Expiry1.15Extrinsic Value100Contract SizeAmericanOptions Type0.1489Delta0.0125Gamma30.68Leverage Ratio-0.1749Theta0.0014Rho4.57Eff Leverage0.0149Vega
Kymera Therapeutics Stock Discussion
Can Kymera's $851M War Chest Deliver on Its Promising Immunology Pipeline Despite Widening Losses?
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$